Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Nov;88(11):974-5.
doi: 10.1136/adc.88.11.974.

Vitamin K supplementation in cystic fibrosis

J H L van Hoorn  1 , J J E Hendriks, C Vermeer, P Ph Forget
Affiliations
Clinical Trial

Vitamin K supplementation in cystic fibrosis

J H L van Hoorn et al. Arch Dis Child. 2003 Nov.

Abstract

The relation between different doses of vitamin K supplementation, several bone markers, and PIVKA-II concentrations in cystic fibrosis (CF) patients compared to controls was evaluated. Results suggest that a increased vitamin K intake may have significant health benefits for children with CF.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Boxplot showing total osteocalcin (t-OC in black), undercarboxylated osteocalcin (u-OC in grey), and carboxylated osteocalcin (c-OC in white) for vitamin K supplementation in CF patients, compared to healthy controls. Vitamin K supplementation is shown in three different groups: CFno = no supplementation; CFlow = <0.25 mg/day; and CFhigh = ⩾1 mg/day. Significant p values are shown.
Figure 2
Figure 2
Boxplot showing PIVKA-II concentrations in CF patients with three different doses of vitamin K supplementation, compared to healthy controls. Significant p values are shown.
See this image and copyright information in PMC

Publication types